UroToday.com· @urotoday · X·· 2 天前评分45
正文 · 原文
SG + EV + Zimberelimab in Treatment-Naive #mUC: Interim Results from Phase 1b TROPHY-U-01 Cohort 7. Presented by Randy Sweis, MD @UChicagoMed. #ESMO26 written coverage by @chavarriagaj @PSH_Urology > https://bit.ly/4sjuOxD #BladderCancer #UrothelialCancer #Immunotherapy @myESMO
313 浏览 · 3 赞 · 3 转发 · 0 回复
会议摘要
4742O按 Proffered paper 1: Genitourinary tumour, renal and urothelial 对上
Sacituzumab Govitecan (SG) Combined With Enfortumab Vedotin (EV) and Zimberelimab (ZIM) in Treatment-Naive Metastatic Urothelial Cancer (mUC): Interim Results From Phase 1b TROPHY-U-01 Cohort 7
https://esmocongress.esmo.org来源：UroToday.com · x.com